CD4 and tuberculosis: Treatment of latent tuberculosis along with cART for people with HIV is a well evidenced intervention, showing an effect in addition to cART on tuberculosis risk, including among individuals with higher CD4+ cell counts [25–27] albeit largely demonstrated in high tuberculosis-incidence settings.